Denise Bevers, Director at Kindred Biosciences, Inc. (KIN), sold 4,627 shares at $5.00 ($23K) on 2021-02-22, disclosed to the SEC on 2021-02-23.
Scheduled sale ($23k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.00 | 5 | $25 | 0.1% |
| 2 | $5.00 | 4,622 | $23K | 99.9% |
| Total | $5.00 avg | 4,627 | $23K | 100% |
| Filing → |
| KIN | SELL | 2021-01-08 | $195K | — | Filing → |
| KIN | SELL | 2020-10-08 | $125K | — | Filing → |
| KIN | SELL | 2020-09-24 | $3K | — | Filing → |